Stem Cell Transplant/CAR T: Register Now for the Myeloma Crowd Round Table Interactive Webcast on Saturday, October 31
Posted: Oct 28, 2020
Stem Cell Transplant/CAR T: Register Now for the Myeloma Crowd Round Table Interactive Webcast on Saturday, October 31 image

Choose to attend one or both of two 2 1/2 hour sessions: Your registration covers the entire day

The Myeloma Crowd Round Table Interactive Webcast on Saturday, October 31 will feature deep dives into stem cell transplantation and CAR T cell research and treatment.

 

Register Now

 

Each session will feature three experts explaining the topic, a moderated discussion of case studies, and more than an hour of audience questions and answers with the full faculty.

We encourage newly diagnosed patients and caregivers to join the first session beginning at 11 am EST.

The second session, starting at 1:30 pm EST, will be more appropriate for “veteran” patients and caregivers, especially those with relapsed and refractory disease.

Linking the two sessions will be a short update on the HealthTree program.

Session One: 11:00 am-1:45 pm EST

  • Natalie Callander, MD, University of Wisconsin-Madison, will talk about who should consider a bone marrow transplant and why.
  • Mark Schroeder, MD, Siteman Cancer Center at Washington University in St. Louis, will describe the actual procedure of transplantation.
  • Dr. Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center in New York, NY, will discuss the latest research finding and recommendations about stem cell transplant.
  • A moderated discussion of case studies will be led by Washington University fellow Zachary Crees, MD.
  • More than one hour of questions submitted by registered viewers for the full faculty.

Session Two: 1:30 pm-4:15 EST

  • Deepu Madduri, MD, Mount Sinai Hospital in New York, NY, will explain what CAR T cells are and how they function.
  • Nikhil Munshi, MD, Dana-Farber Cancer Institute in Boston, MA, will discuss the goals and current state of CAR T cell research.
  • Ravi Vij, MD, MBA, Siteman Cancer Center at Washington University of St. Louis, will explain what role CAR T therapy can play in treatment.
  • A moderated discussion of case  studies led by Washington University fellow Scott Goldsmith, MD.
  • More than one hour of questions submitted by registered viewers for the full faculty.

If you have any questions, please contact Greg Brozeit at greg@crowdcare.org or call 330-990-1090.

 

Register Now

 

Thanks to our Round Table sponsors

.          .    

.           .       

The author Greg Brozeit

about the author
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811